Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mkprovoson May 25, 2010 8:29pm
581 Views
Post# 17130543

RE: RE: EMAIL to SSS

RE: RE: EMAIL to SSSI agree, only ourselves to blame for the decisions we make.  And biopharma is really risky.

By the same token, I do not want to here a word about lawsuit when this thing jumps up in the next few weeks once the anomaly has been discovered and SSS takes off.   If you sold your shares, that is the risk.

If I see anything about lawsuit once this thing takes off, prepare for rebutal on your stupidity.
Bullboard Posts